Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-16

FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's supplemental application for losartan potassium (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)